Page last updated: 2024-11-10

nitrocatechol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nitrocatechol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID4675622
CHEMBL ID288446
SCHEMBL ID70167
MeSH IDM0493125

Synonyms (22)

Synonym
nitrocatechol
6665-98-1
nsc407241
nsc-407241
STK065233
3-nitrobenzene-1,2-diol
CHEMBL288446
AKOS005071755
A835512
3-nitro-1,2-benzenediol
FT-0681777
SCHEMBL70167
AE-0007
3-nitrocatechol
YHKWFDPEASWKFQ-UHFFFAOYSA-N
2,3-dihydroxy-nitrobenzene
J-512969
CS-W006455
mfcd00463758
2-allyloxyethoxyethylmethacrylate
2,3-dihydroxynitrobenzene
DTXSID90901759

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" Treatment of mice with EGCG in combination with tolcapone increased the bioavailability of EGCG and decreased the methylation of plasma norepinephrine: no apparent liver or behavioral toxicity was observed."( Synergistic inhibition of lung cancer cell lines by (-)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase.
Forester, SC; Lambert, JD, 2014
)
0.61

Bioavailability

ExcerptReferenceRelevance
" Treatment of mice with EGCG in combination with tolcapone increased the bioavailability of EGCG and decreased the methylation of plasma norepinephrine: no apparent liver or behavioral toxicity was observed."( Synergistic inhibition of lung cancer cell lines by (-)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase.
Forester, SC; Lambert, JD, 2014
)
0.61
" COMT inhibitors enhance the bioavailability of levodopa to the brain, and therefore are combined with levodopa for the treatment of motor fluctuations in PD."( The inhibition of catechol O-methyltransferase and monoamine oxidase by tetralone and indanone derivatives substituted with the nitrocatechol moiety.
de Beer, AD; Legoabe, LJ; Petzer, A; Petzer, JP, 2021
)
0.83
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID147259Effect on the activity of recombinant rat neuronal nitric oxide synthase as determined with radioactive L-arginine/L-citruline conversion assay2002Bioorganic & medicinal chemistry letters, Jan-07, Volume: 12, Issue:1
Nitrocatechols versus nitrocatecholamines as novel competitive inhibitors of neuronal nitric oxide synthase: lack of the aminoethyl side chain determines loss of tetrahydrobiopterin-antagonizing properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (13.64)29.6817
2010's12 (54.55)24.3611
2020's7 (31.82)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.79 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index38.04 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]